Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferric pyrophosphate + ascorbic acid + cyanocobalamin is a nutritional supplement combination primarily used for the treatment and prevention of iron deficiency anemia and other nutritional deficiencies. The formulation typically contains ferric pyrophosphate as a source of elemental iron, ascorbic acid (Vitamin C) to enhance intestinal iron absorption by maintaining iron in its ferrous state, and cyanocobalamin (Vitamin B12) to support erythropoiesis and nervous system function. Many modern versions of this supplement utilize liposomal delivery technology, which encapsulates the iron to improve bioavailability and significantly reduce common gastrointestinal side effects such as constipation, nausea, and metallic taste. It is frequently used in populations with high iron requirements, including pregnant women and individuals with chronic blood loss or malabsorption syndromes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferric pyrophosphate + ascorbic acid + cyanocobalamin.